S&P 500 Consumer Staples Sector SEC Filings — February 11, 2026

12-02-2026

Iron Mountain Inc filed a Form 8-K on February 12, 2026 (AccNo: 0001020569-26-000009, Size: 15 MB), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are mentioned in the provided filing details. This is a standard earnings-related disclosure with no quantitative performance data available.

12-02-2026

Intelligent Bio Solutions Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0001493152-26-006317), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or quantitative financial data were disclosed in the provided filing description. This is a multi-item filing focused on financial results disclosure.

12-02-2026

Momentus Inc. filed an 8-K on February 12, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders. No details on the specific matters, vote outcomes, or any numerical results such as shares voted, for/against, or abstentions are disclosed. This appears to be a single-item, mandatory disclosure typically related to shareholder meeting results.

12-02-2026

Federal Home Loan Mortgage Corp filed an 8-K on February 12, 2026, under Item 2.02 announcing Results of Operations and Financial Condition, with Financial Statements and Exhibits provided under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics were detailed in the provided filing information. This is a standard voluntary disclosure for financial results.

12-02-2026

PG&E Corp filed an 8-K on February 12, 2026 (AccNo: 0001004980-26-000008), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific quantitative metrics, period-over-period comparisons, guidance, or other numerical data in the available description. No positive or negative performance indicators are detailed.

11-02-2026

AMERICAN REBEL HOLDINGS INC filed an 8-K on 2026-02-11 under Items 3.01 (Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing), 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing signals a core delisting event alongside equity sales and disclosures, with no quantitative financial metrics, transaction values, or performance comparisons disclosed. No positive or offsetting metrics are mentioned.

11-02-2026

PMGC Holdings Inc. filed an 8-K on February 11, 2026 (AccNo: 0001213900-26-015003, Size: 212 KB), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the content of the Regulation FD disclosure or the attached exhibits are provided. No financial metrics, transactions, or performance data are disclosed.

11-02-2026

AST SpaceMobile, Inc. filed a Form 8-K on February 11, 2026 (AccNo: 0001493152-26-006223), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This multi-item filing pertains to financial results disclosure. No specific revenue, earnings, balance sheet impacts, guidance, or quantitative metrics are disclosed in the provided information.

11-02-2026

Granite Point Mortgage Trust Inc. filed an 8-K on February 11, 2026, disclosing Results of Operations and Financial Condition under Item 2.02. Financial Statements and Exhibits are provided under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are disclosed.

11-02-2026

Aeluma, Inc. filed a Form 8-K on February 11, 2026 (AccNo: 0001213900-26-014960, Size: 320 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure of financial results, but no specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics are disclosed in the provided filing information. No positive or negative performance indicators are available.

11-02-2026

Group 1 Automotive Inc filed an 8-K on February 11, 2026, under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other event, transaction values, financial metrics, or exhibits are disclosed in the provided filing information.

11-02-2026

Elite Pharmaceuticals Inc. /NV/ filed an 8-K on February 11, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific core event, transaction details, financial metrics, or quantitative data are disclosed in the filing summary provided. This is a multi-item informational filing likely including exhibits such as a press release.

11-02-2026

Richmond Mutual Bancorporation, Inc. filed an 8-K on February 11, 2026, under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the nature of the other events or the contents of the exhibits are disclosed in the provided filing information. This appears to be a voluntary disclosure with attached exhibits.

11-02-2026

Piedmont Realty Trust, Inc. filed an 8-K on February 11, 2026 (AccNo: 0001042776-26-000009), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, transaction details, guidance, or other quantitative data are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with attached exhibits.

11-02-2026

Morgan Stanley filed a Form 8-K on February 11, 2026, under Item 8.01 (Other Events), indicating disclosure of a material event not covered by other specific 8-K items. No details on the core event, financial impacts, transactions, or quantitative metrics are provided in the filing summary. This appears to be a single-item voluntary disclosure with file size of 322 KB and AccNo 0000950103-26-001967.

• ·File size: 322 KB
• ·AccNo: 0000950103-26-001967
• ·Event Type: General Filing
• ·Sector: NOT_DISCLOSED

11-02-2026

Angel Oak Mortgage REIT, Inc. filed an 8-K on February 11, 2026, specifically under Item 7.01 Regulation FD Disclosure. This is a voluntary disclosure to comply with Regulation FD, but the core content, financial metrics, transactions, or any quantitative data are NOT_DISCLOSED in the provided filing information. No positive, negative, or flat performance metrics are mentioned.

11-02-2026

ECA Marcellus Trust I filed a Form 8-K on February 11, 2026, under Item 2.02 announcing Results of Operations and Financial Condition, with Item 9.01 providing Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, or performance details (positive, negative, or flat) are disclosed in the provided filing information.

11-02-2026

Actelis Networks Inc filed a Form 8-K on February 11, 2026 (AccNo: 0001213900-26-014904), reporting solely under Item 8.01 Other Events. No details on the nature of the event, transaction values, financial metrics, or impacts are disclosed. This is a single-item voluntary filing with no quantitative data or scheduled events mentioned.

11-02-2026

PepsiCo Inc. filed an 8-K on February 11, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the other event, financial statements, or exhibits are provided in the filing summary. No quantitative metrics, transactions, or impacts are disclosed.

11-02-2026

Motorola Solutions, Inc. filed an 8-K on February 11, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing summary. This appears to be a standard earnings-related disclosure with no detailed performance data available.

11-02-2026

Phoenix Motor Inc. filed an 8-K on February 11, 2026 (AccNo: 0001493152-26-006203), reporting under Item 3.03 for material modifications to rights of security holders, Item 5.03 for amendments to articles of incorporation or bylaws or change in fiscal year, and Item 9.01 for financial statements and exhibits. This is a multi-item mandatory disclosure with no quantitative financial metrics, transaction values, or performance comparisons disclosed. Specific details on the nature, scope, or impact of the modifications or amendments are not provided.

11-02-2026

QuidelOrtho Corp filed an 8-K on February 11, 2026 (AccNo: 0001906324-26-000003), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, period-over-period comparisons, or other quantitative details are disclosed in the filing summary. This appears to be a standard earnings-related disclosure with exhibits likely including press releases or financial tables.

11-02-2026

Moog Inc. filed a Form 8-K on February 11, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders, indicating results from a shareholder meeting were disclosed. This is a single-item filing with no specific details on proposals, vote outcomes, or any quantitative metrics provided in the excerpt. No financial impacts, guidance changes, or other material events are mentioned.

11-02-2026

Dakota Gold Corp. filed a Form 8-K on February 11, 2026 (AccNo: 0001104659-26-013353, Size: 564 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, financial statements, or exhibits are disclosed in the provided filing information. This is a multi-item filing with no quantitative metrics, transactions, or directional impacts mentioned.

11-02-2026

SOUTH DAKOTA SOYBEAN PROCESSORS LLC filed a Form 8-K on February 11, 2026, reporting solely under Item 8.01 Other Events. No specific details regarding the event, financial metrics, transactions, or impacts are disclosed in the provided filing information. This appears to be a single-item, voluntary disclosure.

12-02-2026

Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0001062993-26-000822, Size: 587 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the core event, transaction values, financial metrics, or performance comparisons disclosed in the provided information. No quantitative data, period-over-period changes, positive or negative metrics, or strategic implications are available.

12-02-2026

Hyatt Hotels Corp filed an 8-K on 2026-02-12 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing metadata. This is a multi-item voluntary earnings-related disclosure.

12-02-2026

BioXcel Therapeutics, Inc. filed a Form 8-K on February 12, 2026, under Item 8.01 Other Events. No specific details regarding the nature of the other event, financial impacts, or quantitative metrics are disclosed in the provided filing information. This appears to be a single-item voluntary disclosure.

12-02-2026

AMERICAN ELECTRIC POWER CO INC filed an 8-K on 2026-02-12 under Item 2.02 reporting Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing announcing financial results with no specific revenue, earnings, or other quantitative metrics disclosed in the provided information. No positive or negative performance indicators, comparisons, or guidance changes are detailed.

12-02-2026

Sylvamo Corp filed an 8-K on February 12, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, or other quantitative metrics were disclosed in the provided filing details. This constitutes a standard earnings-related disclosure with no detailed performance data available.

12-02-2026

Kelly Services Inc filed an 8-K on 2026-02-12 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no detailed financial data available.

12-02-2026

Avadel Pharmaceuticals PLC filed an 8-K on 2026-02-12 disclosing the completion of an acquisition or disposition of assets under Item 2.01, changes in control of the registrant under Item 5.01, and notice of delisting or failure to satisfy listing standards under Item 3.01. The filing also reports termination of a material definitive agreement (Item 1.02), material modifications to rights of security holders (Item 3.03), departures or elections of directors/officers and compensatory arrangements (Item 5.02), and amendments to articles of incorporation or bylaws or change in fiscal year (Item 5.03), along with Regulation FD disclosure (Item 7.01) and financial statements/exhibits (Item 9.01). No quantitative financial metrics, deal values, parties, or specific terms were disclosed.

12-02-2026

Belden Inc. filed an 8-K on February 12, 2026, under Item 2.02 announcing Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the filing summary provided. This appears to be a standard earnings-related disclosure with no detailed performance data available.

12-02-2026

IPG Photonics Corp filed an 8-K on 2026-02-12 reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. This is a multi-item filing typical for earnings releases. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing details.

12-02-2026

Diodes Inc. filed an 8-K on February 12, 2026 (AccNo: 0001193125-26-048964), disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing related to financial results, but no specific revenue, earnings, guidance, or other quantitative metrics are mentioned. No positive or negative performance details, period-over-period comparisons, or forward-looking statements are provided in the filing information.

12-02-2026

Under Armour, Inc. filed an 8-K on February 12, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on the officer, position affected, reason for change, or any quantitative metrics are disclosed.

12-02-2026

Lincoln Electric Holdings Inc filed an 8-K on February 12, 2026 (AccNo: 0000059527-26-000003, Size: 1 MB), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons were disclosed in the provided filing information. This is a standard earnings-related disclosure without quantified metrics.

• ·Event Type: Financial Results
• ·Source: us_sec
• ·Sector: NOT_DISCLOSED

12-02-2026

Fresh Del Monte Produce Inc filed an 8-K on 2026-02-12 disclosing entry into a material definitive agreement under Item 1.01. The filing also includes financial statements and exhibits under Item 9.01. No details on the agreement terms, parties, financial impact, or quantitative metrics are provided.

12-02-2026

Rivian Automotive, Inc. filed a Form 8-K on February 12, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), indicating a voluntary disclosure of financial results typically accompanying an earnings release. This is a multi-item filing with no specific revenue, earnings, balance sheet effects, guidance, or other quantitative metrics explicitly stated in the provided information. No positive, negative, or flat performance indicators are disclosed.

12-02-2026

Teladoc Health, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001477449-26-000002), disclosing an Item 5.02 event related to the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or financial terms are disclosed. No quantitative metrics, performance comparisons, or other financial data are mentioned.

12-02-2026

Edgemode, Inc. filed an 8-K on February 12, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, timing, or any quantitative metrics are provided.

12-02-2026

Yelp Inc filed a Form 8-K on February 12, 2026 (AccNo: 0001345016-26-000011, Size: 5 MB), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet effects, guidance, or period-over-period metrics are disclosed in the provided filing details. This is a standard multi-item filing for financial results announcement with no quantitative data available.

• ·AccNo: 0001345016-26-000011
• ·File Size: 5 MB
• ·Sector: not specified

12-02-2026

American Well Corp filed an 8-K on February 12, 2026, reporting under Item 2.02 Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or other quantitative financial details are disclosed in the provided filing information. This constitutes a standard voluntary earnings-related disclosure without directional performance indicators.

• ·Filing Accession Number: 0001193125-26-048737
• ·File Size: 714 KB
• ·ANALYSIS CONFIDENCE: LOW (<50%) - Critical missing information: all financial metrics (revenue, earnings, EPS, margins), period-over-period comparisons (YoY/QoQ), guidance/outlook, balance sheet details, cash/debt changes, scheduled events (earnings calls), named executives/products/initiatives, insider activity, forward-looking statements, and actual results content from Items 2.02/9.01

12-02-2026

Thermo Fisher Scientific Inc. filed an 8-K on February 12, 2026 (AccNo: 0001140361-26-005014), reporting under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details, transaction values, financial metrics, positive or negative impacts, or period-over-period comparisons are disclosed in the provided filing summary.

12-02-2026

Haemonetics Corp filed an 8-K on February 12, 2026, reporting under Item 7.01 Regulation FD Disclosure. No specific details on the disclosed information, financial metrics, transactions, or events are provided in the filing summary. This is a voluntary disclosure with no quantitative data or period-over-period comparisons mentioned.

12-02-2026

Constellation Brands, Inc. filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details regarding the key position affected, whether it is an appointment or resignation, reasons for the change, or any governance implications are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

12-02-2026

Mohawk Industries Inc filed an 8-K on February 12, 2026 (AccNo: 0000851968-26-000005, Size: 2 MB), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, period-over-period comparisons, or other quantitative financial metrics were disclosed in the provided filing details. No positive, negative, or flat performance indicators were mentioned.

• ·Filing Accession Number: 0000851968-26-000005
• ·Filing Size: 2 MB

12-02-2026

Morningstar, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001289419-26-000009, Size: 8 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results, but no specific revenue, earnings, margins, or period-over-period comparisons are explicitly stated. No positive or negative metrics are detailed in the provided filing information.

12-02-2026

Celcuity Inc. filed an 8-K on February 12, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. The filing also includes Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. Specific details including names, positions, reasons, or compensation are NOT_DISCLOSED.

12-02-2026

Olympic Steel Inc filed a Form 8-K on February 12, 2026, reporting Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on vote outcomes, events, financial statements, or exhibits are disclosed in the provided filing summary. This is a multi-item informational filing typical after shareholder meetings.

12-02-2026

Middlefield Banc Corp filed an 8-K on February 12, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, names of individuals, reasons for the change, or any quantitative data such as compensation amounts are disclosed. Sector information is not specified.

12-02-2026

Keurig Dr Pepper Inc. filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on affected positions, individuals involved, reasons for change, or financial impacts are provided. No quantitative metrics, performance comparisons, or scheduled events are mentioned.

12-02-2026

Helio Corp filed a Form 8-K on February 12, 2026, under Item 2.04 disclosing a triggering event that accelerates or increases a direct financial obligation or an obligation under an off-balance sheet arrangement, Item 7.01 for Regulation FD Disclosure, and Item 9.01 for Financial Statements and Exhibits. No specific details on the nature of the triggering event, dollar values, financial metrics, or other quantitative data are provided in the filing summary. This multi-item filing signals potential financial stress but lacks context on impacts.

12-02-2026

Topgolf Callaway Brands Corp. filed an 8-K on February 12, 2026, reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or other financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed quantitative data available.

12-02-2026

Mueller Water Products, Inc. filed an 8-K on February 12, 2026, reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific vote outcomes, numerical results, matters proposed, or other details are disclosed in the provided filing summary. This is an informational disclosure with no financial metrics or directional implications mentioned.

12-02-2026

Limoneira CO filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected position, individual names, appointment or resignation status, reasons, timing, or any quantitative data are disclosed.

12-02-2026

Perfect Moment Ltd. filed an 8-K on February 12, 2026 (AccNo: 0001493152-26-006460), disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing announcing financial results with no specific revenue, earnings, guidance, or other quantitative metrics disclosed in the provided information. Sector details are not specified.

12-02-2026

Insight Molecular Diagnostics Inc. filed an 8-K on February 12, 2026, disclosing entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details, dollar values, financial impacts, or performance metrics (positive, negative, or flat) are disclosed in the provided filing summary.